These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34508266)

  • 21. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
    Harrison MJ; Dixon WG; Watson KD; King Y; Groves R; Hyrich KL; Symmons DP; ;
    Ann Rheum Dis; 2009 Feb; 68(2):209-15. PubMed ID: 18385277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2.
    McInnes IB; Chakravarty SD; Apaolaza I; Kafka S; Hsia EC; You Y; Kavanaugh A
    RMD Open; 2019; 5(2):e000990. PubMed ID: 31565242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.
    Malottki K; Barton P; Tsourapas A; Uthman AO; Liu Z; Routh K; Connock M; Jobanputra P; Moore D; Fry-Smith A; Chen YF
    Health Technol Assess; 2011 Mar; 15(14):1-278. PubMed ID: 21439251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-modifying antirheumatic drug therapy for spondyloarthropathies: advances in treatment.
    Mease PJ
    Curr Opin Rheumatol; 2003 May; 15(3):205-12. PubMed ID: 12707572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion.
    Gill H; Majithia V
    Clin Rheumatol; 2008 Jan; 27(1):121-3. PubMed ID: 17643185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials.
    Huang Y; Fan Y; Liu Y; Xie W; Zhang Z
    Clin Rheumatol; 2019 Oct; 38(10):2765-2776. PubMed ID: 31087226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs.
    Strangfeld A; Richter A; Siegmund B; Herzer P; Rockwitz K; Demary W; Aringer M; Meißner Y; Zink A; Listing J
    Ann Rheum Dis; 2017 Mar; 76(3):504-510. PubMed ID: 27405509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactive arthritis: newer developments.
    Flores D; Marquez J; Garza M; Espinoza LR
    Rheum Dis Clin North Am; 2003 Feb; 29(1):37-59, vi. PubMed ID: 12635499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.
    Almoallim H; Jali I; Wali G
    Joint Bone Spine; 2013 Jul; 80(4):426-8. PubMed ID: 23453475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving patterns of reactive arthritis.
    Hayes KM; Hayes RJP; Turk MA; Pope JE
    Clin Rheumatol; 2019 Aug; 38(8):2083-2088. PubMed ID: 30919146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to treatment with tocilizumab of reactive arthritis induced by intravesical bacillus Galmette-Guérin unresponsive to DMARDs.
    Kwan K; Bharadwaj S; Inderjeeth C
    Int J Rheum Dis; 2012 Aug; 15(4):e73-5. PubMed ID: 22898231
    [No Abstract]   [Full Text] [Related]  

  • 33. An overview of reactive arthritis.
    Pennisi M; Perdue J; Roulston T; Nicholas J; Schmidt E; Rolfs J
    JAAPA; 2019 Jul; 32(7):25-28. PubMed ID: 31169570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum.
    Carter JD; Gerard HC; Hudson AP
    Ann Rheum Dis; 2008 Aug; 67(8):1181-3. PubMed ID: 18299302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection and musculoskeletal conditions: Reactive arthritis.
    Rihl M; Klos A; Köhler L; Kuipers JG
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1119-37. PubMed ID: 17127200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reactive arthritis].
    Stegert M
    Ther Umsch; 2023 Feb; 80(1):34-38. PubMed ID: 36659843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N; Betts KA; Messali AJ; Skup M; Garg V
    Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence and adherence of biologics in US patients with psoriatic arthritis: analyses from a claims database.
    Oelke KR; Chambenoit O; Majjhoo AQ; Gray S; Higgins K; Hur P
    J Comp Eff Res; 2019 Jun; 8(8):607-621. PubMed ID: 30912454
    [No Abstract]   [Full Text] [Related]  

  • 40. Knowledge and Perceptions of Reactive Arthritis Diagnosis and Management Among Healthcare Workers During the COVID-19 Pandemic: Online Survey.
    Bekaryssova D; Joshi M; Gupta L; Yessirkepov M; Gupta P; Zimba O; Gasparyan AY; Ahmed S; Kitas GD; Agarwal V
    J Korean Med Sci; 2022 Dec; 37(50):e355. PubMed ID: 36573387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.